However, a transcriptome analysis performed by Rosner et al. [43] revealed that activation of the PGE2-EP2/EP4 signaling pathway in CD8+ tumor-infiltrating lymphocytes was associated with improved recurrence-free survival in non-small cell lung cancer patients. The gene discussed is CD8A; the disease is non-small cell lung carcinoma.